|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Deferred offering costs | |||||||||||||
| Cash | |||||||||||||
| Prepaid expenses | |||||||||||||
| Note receivable, net of original issuance discount | |||||||||||||
| Derivative asset — Note Receivable, at fair value | |||||||||||||
| Total current assets | |||||||||||||
| Cash held in Trust Account | |||||||||||||
| Total Assets | |||||||||||||
| Liabilities and Shareholders’ Deficit | |||||||||||||
| Accrued expenses | |||||||||||||
| Accounts payable and accrued expenses | |||||||||||||
| Due to Related Party | |||||||||||||
| Related Party | |||||||||||||
| Total due to Related Party | |||||||||||||
| Convertible Promissory Note, at fair value | |||||||||||||
| Working Capital Loans, at fair value | |||||||||||||
| Note payable, net of original issuance discount | |||||||||||||
| Derivative Liability — Note Payable, at fair value | |||||||||||||
| Capital Contribution Note, at fair value | |||||||||||||
| Total current liabilities | |||||||||||||
| Warrant liability | |||||||||||||
| Deferred underwriting fees | |||||||||||||
| Total liabilities | |||||||||||||
| Class A ordinary shares subject to possible redemption, 1,364,882 and 2,214,859 shares at redemption value of $11.64 and $11.19 per share as of June 30, 2024 and December 31, 2023, respectively | |||||||||||||
| Class A Ordinary Shares | |||||||||||||
| Total class A ordinary shares subject to possible redemption, 1,364,882 and 2,214,859 shares at redemption value of $11.64 and $11.19 per share as of June 30, 2024 and December 31, 2023, respectively | |||||||||||||
| Shareholders’ Deficit: | |||||||||||||
| Ordinary shares | |||||||||||||
| Class A Ordinary Shares | |||||||||||||
| Class B Ordinary Shares | |||||||||||||
| Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 7,500,000 shares issued and outstanding at June 30, 2023 and December 31, 2022 | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Shareholders’ deficit | |||||||||||||
| Class B Ordinary Shares | |||||||||||||
| Total shareholders’ deficit | |||||||||||||
| Total Liabilities and Shareholders’ Deficit | |||||||||||||
Loading...
